EMA Focuses on Greater International Collaboration - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

EMA Focuses on Greater International Collaboration


Pharmaceutical Technology Europe


References

1. EMA website, "Partners & Networks," http://www.ema.europa.eu/, accessed 7 Sept. 2012.

2. EMA website, "Road Map to 2015," http://www.ema.europa.eu/, accessed 7 Sept. 2012.

3. K. Tadano, "PMDA's International Strategic Plan and its Implementation" (PMDA website), http://www.pharm.kitasato-u.ac.jp/, accessed 7 Sept. 2012.

4. Centre for Innovation in Regulatory Science (CIRS) website, "May 2012 Slide of the Month," http://cirsci.org/, accessed 7 Sept. 2012.

5. EMA website, "Report on interactions between the Japanese Ministry of Health, Labour and Welfare (MHLW)/Pharmaceuticals and Medical Devices Agency (PMDA) and the European Medicines Agency (EMA)," http://www.ema.europa.eu/, accessed 7 Sept. 2012.

6. Y. Hayashi, "EU, USA and Japan (II)– Reports from Regulators on Exchange Assignments" (PMDA website), http://www.pmda.go.jp/, accessed 7 Sept. 2012.

7. EMA website, "European Union — Japan orphan medicines cooperation". http://www.ema.europa.eu/, accessed 7 Sept. 2012.

8. EC website, "Medicines Regulation: Transatlantic Administrative Simplification Action Plan," http://ec.europa.eu/, accessed 7 Sept. 2012.

9. EMA website, "Enhancing GMP Inspection Cooperation Between the EMA and FDA," http://www.ema.europa.eu/, accessed 10 Sept. 2012.

10. WHO website, "Essential medicines for children". http://www.who.int/, accessed 7 Sept. 2012.

11. E. Silverman, "Clinical Trial Deaths In India Dropped" (Pharmalot website, 2012), http://www.pharmalot.com/, accessed 7 Sept. 2012.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology Europe,
Click here